…
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application. The company serves technology, automotive, financial services, retail, government, and healthcare sectors. The company was formerly known as Appen Holdings Pty Limited and changed its name to Appen Limited in October 2014. Appen Limited was founded in 1996 and is headquartered in Sydney, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Appen Ltd supplies annotated training data and related services for machine learning and AI via a global crowdsourced workforce and data-labeling platform. Long-term growth may be supported by rising enterprise demand for labeled datasets, multilingual data needs and expansion of managed services, which could appeal to investors seeking exposure to the AI data supply chain.
Key risks include reliance on a small number of large technology clients, strong competition and pricing pressure from in-house teams and larger vendors, and regulatory or privacy scrutiny of data collection practices.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -33.78M | -19.99M | -188.24M | -239.07M | 35.88M |
| Net income | -33.84M | -20.01M | -118.08M | -444.07M | 28.52M |
| Selling general administrative | 51.51M | 76.55M | 89.22M | 95.71M | 71.53M |
| Selling and marketing expenses | - | - | 10.61M | - | - |
| Gross profit | 11.62M | 61.18M | -34.79M | 388.13M | 447.15M |
| Reconciled depreciation | 31.33M | 23.32M | 35.15M | 41.58M | 35.04M |
| Ebit | -32.64M | -19.98M | -124.51M | -33.57M | 38.76M |
| Ebitda | 15.95M | 3.34M | -89.37M | 8.01M | 73.80M |
| Depreciation and amortization | 48.59M | 23.32M | 35.15M | 41.58M | 35.04M |
| Operating income | -32.64M | -21.02M | -85.97M | -33.57M | 38.76M |
| Other operating expenses | 390.53M | 392.65M | 497.27M | 417.44M | 403.87M |
| Interest expense | 1.08M | 1.24M | 1.77M | 0.49M | 0.63M |
| Tax provision | 0.04M | 0.02M | -6.87M | 0.00M | 7.36M |
| Interest income | 0.77M | 0.48M | 0.37M | 3.56M | 0.01M |
| Net interest income | 0.07M | -0.34M | -0.81M | -0.81M | -1.36M |
| Income tax expense | 0.06M | 0.02M | -10.35M | 205.00M | 7.36M |
| Total revenue | 357.89M | 234.28M | 411.31M | 388.13M | 447.15M |
| Total operating expenses | 44.26M | 73.78M | 97.28M | 417.44M | 403.87M |
| Cost of revenue | 346.27M | 318.87M | 446.10M | 237.71M | 268.38M |
| Total other income expense net | -1.14M | 1.02M | -102.28M | -205.50M | -2.88M |
| Net income from continuing ops | -21.82M | -20.01M | -118.08M | -239.07M | 28.52M |
| Net income applicable to common shares | - | -20.01M | -118.08M | -239.07M | 28.52M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 228.63M | 170.59M | 227.39M | 254.94M | 498.92M |
| Intangible assets | 23.71M | 30.18M | 39.87M | 56.45M | 67.13M |
| Other current assets | 7.64M | 26.98M | 8.67M | 30.45M | 12.95M |
| Total liab | 86.77M | 56.27M | 91.39M | 106.95M | 107.05M |
| Total stockholder equity | 141.87M | 114.32M | 136.00M | 147.99M | 391.87M |
| Other current liab | 26.99M | 26.20M | 29.04M | 37.25M | 16.15M |
| Common stock | 549.92M | 366.71M | 469.61M | 262.92M | 262.92M |
| Capital stock | 366.71M | 366.71M | 320.44M | 262.92M | 262.92M |
| Retained earnings | -606.28M | -381.17M | -531.21M | -243.09M | -4.02M |
| Other liab | - | - | - | 34.84M | 33.41M |
| Good will | - | - | - | 53.11M | 247.65M |
| Other assets | - | - | 0.00M | 5.50M | 4.69M |
| Cash | 89.71M | 54.81M | 47.12M | 23.43M | 47.88M |
| Total current liabilities | 71.06M | 43.86M | 69.84M | 65.09M | 66.61M |
| Current deferred revenue | 18.45M | - | 16.33M | - | 20.14M |
| Net debt | -67.74M | -43.77M | -28.90M | -13.25M | -32.82M |
| Short term debt | 6.23M | 3.58M | 4.58M | 3.15M | 5.00M |
| Short long term debt total | 21.97M | 11.04M | 18.22M | 10.18M | 15.06M |
| Other stockholder equity | - | - | - | -8.02M | 132.97M |
| Property plant equipment | - | - | - | 12.79M | 16.68M |
| Total current assets | 183.99M | 129.18M | 156.45M | 124.67M | 162.76M |
| Long term investments | 0.50M | 1.43M | 1.45M | 2.42M | - |
| Net tangible assets | - | - | - | 38.43M | 77.08M |
| Net receivables | 85.74M | 46.72M | 99.09M | 64.28M | 89.24M |
| Long term debt | - | - | - | 0.00M | 0.00M |
| Inventory | 0.90M | 0.67M | 1.57M | 0.65M | 12.69M |
| Accounts payable | 19.39M | 14.08M | 19.89M | 24.68M | 25.31M |
| Accumulated other comprehensive income | 198.23M | 128.78M | 197.60M | 128.15M | 132.97M |
| Non currrent assets other | 1.26M | 1.22M | 18.60M | 0.42M | 0.63M |
| Non current assets total | 44.64M | 41.42M | 70.94M | 130.27M | 336.15M |
| Capital lease obligations | 9.40M | 11.04M | 12.43M | 10.18M | 15.06M |
| Long term debt total | - | - | - | 7.03M | 10.06M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -13.08M | -20.89M | -32.12M | -50.82M |
| Change to liabilities | - | - | - | -1.74M | 8.62M |
| Total cashflows from investing activities | -25.80M | -19.83M | -31.48M | -32.12M | -50.82M |
| Net borrowings | - | - | 0.00M | -4.51M | -4.88M |
| Total cash from financing activities | -7.52M | 57.22M | 79.36M | -9.53M | -14.14M |
| Change to operating activities | - | - | - | 1.00M | -0.25M |
| Net income | -33.84M | -20.01M | -173.25M | -444.07M | 28.52M |
| Change in cash | 1.19M | 41.38M | 12.57M | -24.45M | -12.61M |
| Begin period cash flow | 88.52M | 32.15M | 34.41M | 47.88M | 60.49M |
| End period cash flow | 89.71M | 54.81M | 47.12M | 23.43M | 47.88M |
| Total cash from operating activities | 35.62M | -1.01M | -34.56M | -402.49M | 53.92M |
| Issuance of capital stock | - | 42.14M | 57.44M | - | - |
| Depreciation | 48.59M | - | 52.95M | 41.58M | 35.04M |
| Other cashflows from investing activities | - | -18.04M | -28.33M | -4.19M | -2.73M |
| Dividends paid | - | - | 0.00M | 5.02M | 9.27M |
| Change to inventory | 0.11M | 0.20M | -0.63M | - | - |
| Change to account receivables | 18.27M | -1.47M | 42.93M | 4.98M | -20.15M |
| Sale purchase of stock | - | 42.14M | 57.44M | - | - |
| Other cashflows from financing activities | -7.52M | 22.18M | 28.91M | -4.51M | 5.12M |
| Change to netincome | - | - | - | 207.69M | 3.42M |
| Capital expenditures | 6.25M | 2.89M | 19.85M | 27.93M | 23.09M |
| Change in working capital | 14.89M | -2.69M | 5.54M | 0.18M | 0.01M |
| Stock based compensation | - | - | 8.35M | - | - |
| Other non cash items | 5.98M | 1.68M | 80.19M | 402.49M | -63.56M |
| Free cash flow | 29.37M | -3.96M | -42.79M | -430.42M | 30.83M |
Sector: Technology Industry: Information Technology Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| APX Appen Ltd |
-0.06 4.91% |
1.06 | - | 9.25 | 1.20 | 2.11 | 0.64 | 9.35 |
| NXT NEXTDC Ltd |
0.55 5.58% |
10.40 | 82.08 | 2000.00 | 15.09 | 0.81 | 15.00 | 20.30 |
| DTL Data 3 Ltd |
-0.60 4.03% |
14.28 | 42.51 | 32.68 | 2.55 | 23.86 | 2.17 | 23.03 |
| MAQ Macquarie Technology Group Ltd |
-2.76 5.25% |
49.86 | 42.44 | 68.97 | 3.48 | 2.06 | 3.60 | 12.18 |
| DUG DUG Technology Ltd |
-0.07 4.59% |
1.46 | 76.25 | 16.95 | 2.40 | 2.73 | 1.94 | 7.46 |
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application. The company serves technology, automotive, financial services, retail, government, and healthcare sectors. The company was formerly known as Appen Holdings Pty Limited and changed its name to Appen Limited in October 2014. Appen Limited was founded in 1996 and is headquartered in Sydney, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark Ronald Gerard Brayan M.B.A., MBA | MD, CEO & Exec. Director | 1964 |
| Mr. Kevin B. Levine B.Com., BAcc, Bcom, CA | Chief Financial Officer | NA |
| Mr. Wilson Pang | Chief Technology Officer | NA |
| Ms. Rosalie Talbot Duff | Head of Investor Relations | NA |
| Mr. Carl Middlehurst | VP, Company Sec. & Gen. Counsel | NA |
| Mr. Ryan Kolln | VP of Corp. Devel. | NA |
| Andrea Clayton | Chief People Officer | NA |
| Dr. Roc Tian M.A., Ph.D. | Sr. VP & GM of China, Japan and Korea | NA |
| Ms. Sujatha Sagiraju | Chief Product Officer | NA |
| Mr. Eric De Cavaignac | Chief Transformation Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.